The First Affiliated Hospital of Xinjiang Medical University
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-10-06 | NCT06862869 | |
| A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease | Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Not applicable | 2026-09-22 | NCT07582731 | |
| A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy | Primary Membranous Nephropathy | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-11 | NCT05707377 | |
| A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease | Angina Pectoris, Arterial Occlusive Diseases, Chest Pain, Infarction, Necrosis, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, intermediate coronary syndrome, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Not stated | 2026-09-04 | NCT06295679 | |
| BDB-001 Phase III Trial in ANCA-Associated Vasculitis | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, immune system disorder, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 3 | 2026-08-13 | NCT07168161 | |
| Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens | Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, respiratory system disorder, respiratory tract infectious disorder, severe acute respiratory syndrome, viral infectious disease | Recruiting | Not stated | 2026-07-10 | NCT07694648 | |
| Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors | cardiovascular disorder, heart disorder, heart failure | Not yet recruiting | Not applicable | 2026-06-03 | NCT07622394 | |
| Differences in Pelvic Floor Motion Level Among Chinese Women and Construction of an Assessment System | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urinary Incontinence, Stress, Urination Disorders, Urogenital Diseases, Urological Manifestations, urinary system disorder | Not yet recruiting | Not stated | 2026-05-27 | NCT07608146 | |
| Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-02-27 | NCT05581303 | |
| Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial) | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, acute pancreatitis, multiple organ dysfunction syndrome, pancreas disorder, pancreatitis | Recruiting | Phase 4 | 2025-06-15 | NCT03547232 | |
| Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock | Vasodilatory Shock | Recruiting | Phase 3 | 2025-01-23 | NCT06351150 | |
| A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer | Advanced Renal Cancer | Active, not recruiting | Phase 3 | 2024-10-15 | NCT04523272 |